Drug services provider Frontage refiles for HK listing

Jonathan Breen

March 13, 2019 04:15 am

unilab_Adobe_230x150 — Life scientists researching in laboratory. Female young scientist and her post doctoral supervisor microscoping in their working environment. Healthcare and biotechnology. | kasto - stock.adobe.com

China’s Frontage Holdings Corp, which provides support to pharmaceutical companies, has refiled a draft IPO prospectus with Hong Kong’s stock exchange.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Equity IPOs Equity Bank of America Hong Kong SAR Asia Greater China Northeast Asia Asia Pacific Emerging Markets Goldman Sachs

JB

Jonathan Breen

Equities editor GlobalCapital Asia